ResearcherYokohama City UniversityActive in the last 2 years

Juri Ichikawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5089570915. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model. Co-author DOI 10.1111/cas.70246 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shingo Kato · 1 shared paper, 2026 · strength 0.26
- Paper A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model. DOI 10.1111/cas.70246 ↗
Yukihiko Hiroshima · 1 shared paper, 2026 · strength 0.26
- Paper A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model. DOI 10.1111/cas.70246 ↗
Tomohiko Tamura · 1 shared paper, 2026 · strength 0.26
- Paper A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model. DOI 10.1111/cas.70246 ↗
Shin Maeda · 1 shared paper, 2026 · strength 0.26
- Paper A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model. DOI 10.1111/cas.70246 ↗
Itaru Endo · 1 shared paper, 2026 · strength 0.26
- Paper A Combinatorial Effect of Immune Checkpoint Inhibitors and CD40 Agonistic Antibody in Murine Pancreatic Cancer Model. DOI 10.1111/cas.70246 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.